News and blogs

Let's clear up the confusion around testing — because there’s no good reason to put off getting an HIV test

New study shows people living with HIV still expect far less from their lives compared to those who are HIV-negative, despite near-normal life expectancy.

On World Development Information Day, we look at an innovative HIV self-testing app being introduced to all UNAIDS Fast-Track Cities which aims to bridge the divide between testing, treatment and care.

Mandatory HIV testing is a ‘knee-jerk and untenable reaction’, and it ultimately does not get more people testing for HIV.

A study of gay men in Malawi reveals very low levels of HIV testing and treatment access nationwide – with distinct geographic disparities in HIV prevalence that need to be taken into consideration and addressed.

Key HIV drugs added to the list of medicines critical to public health, including tenofovir for HIV prevention, and dolutegravir.

First update on cryptococcus in the era of antiretroviral treatment expansion reveals disproportionate burden in sub-Saharan Africa and a need for better treatment options.

There is a high appetite for increased access to pre-exposure prophylaxis (PrEP) among gay app users in Switzerland, according to research looking into the need for a national PrEP programme.

Reducing the number of age-disparate relationships in east and southern Africa could help to decrease HIV infection rates among young women in the region.

There has been a vast decline in mortality among people with HIV who get on antiretroviral treatment – but who are we leaving behind?

The country with the third largest HIV epidemic moves to a test-and-treat strategy that aims to get everyone on antiretroviral therapy.

Women’s views on voluntary male medical circumcision form an important part of the delivery and mass roll-out of this HIV prevention strategy.

A number of southern African countries are making good progress towards the 90-90-90 Fast-Track Targets, but efforts to reach younger populations need to be redoubled.

This World AIDS Day we've chosen ten pivotal events from the history of the HIV epidemic you should know about.

The game-changing drug, Truvada – the only drug approved for PrEP – will be offered to groups considered at risk of HIV.

We count down the top five things that everybody should know about HIV - from AIDS, to testing, to symptoms, to treatment.